Quality of Care
July 19, 2018
We examine utilization, quality, and expenditures among Medicare beneficiaries receiving care at federally qualified health centers and compare outcomes among those attributed to 1 of 3 recognition programs versus none.
Insights on Site-of-Care Cancer Research: Both Quality and Cost Information Are Necessary to Guide Policy
July 19, 2018
The implementation of alternative payment models that successfully capture clinical heterogeneity—without adding unacceptable levels of administrative complexity—may be equally (if not more) important than site-neutral payment policies.
July 18, 2018
After 5 years of research, the Hutchinson Institute for Cancer Outcomes Research has released a report that is the first in the nation to publicly report clinic-level quality measures linked to cost in oncology.
July 16, 2018
Quality measurement has been around for nearly 2 decades and in that time measures have evolved and also proliferated to the point of placing considerable burden on physicians and health systems. New efforts are being made to streamline current measures, fill in gaps, and harmonize measures across programs.
July 13, 2018
CMS Administator Seema Verma said the changes are designed to reduce administrative burdens for physicians so they can spend more time with patients. A group representing community oncologists said a reimbursement change for new drugs could have unintended consequences.
July 12, 2018
Providers, payers, and patients looking to do research on a clinical guideline need to get busy: They only have this weekend to download thousands of pages from federally funded websites that will close due to federal budget cuts in President Donald Trump’s budget.
July 09, 2018
An updated review of value-based insurance design (VBID) as a strategy for increasing consumer adherence to prescription medications found moderate-quality evidence that such strategies are useful for increasing the use of high-value drug classes while lowering cost sharing.
July 06, 2018
Research presented at the 2018 American Society of Clinical Oncology Annual Meeting identified predictors of long-term survival and health-related quality of life (QoL) in patients with newly diagnosed multiple myeloma (MM).